๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase I and pharmacologic study of oral ftorafur and X ray therapy in advanced gastrointestinal cancer

โœ Scribed by John E. Byfield; Thomas R. Sharp; Cecil L. Hornbeck; Sallie S. Frankel; Ronald A. Floyd; John C. Griffiths

Publisher
Elsevier Science
Year
1985
Tongue
English
Weight
816 KB
Volume
11
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase I-II study of ftorafur and methyl-
Phase I-II study of ftorafur and methyl-ccnu in advanced colorectal cancer
โœ Robert J. Belt; Ronald Stephens ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 316 KB ๐Ÿ‘ 2 views

The combination of Ftorafur (NSC-148958) and methyl-CCNU (NSC-95441) was evaluated in 36 patients with advanced colorectal cancer. The principle toxicities encountered were myelosuppression, gastrointestinal, and neurological. There were no complete responses and only 5/34 (14.7%) patients achieved

Phase I/II study of carboplatin and oral
Phase I/II study of carboplatin and oral etoposide with granulocyte-colony stimulating factor in advanced nonsmall cell lung cancer
โœ Giuseppe Frasci; Giovanni Persico; Giuseppe Perillo; Giuseppe Comella; Pasquale ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 665 KB

Background. A combination of carboplatin (CBDCA) and oral etoposide is better tolerated than, and as effective as, more aggressive chemotherapy regimens in patients with advanced nonsmall cell lung cancer (NSCLC). A Phase 1/11 study was conducted to determine whether the addition of the granulocyte-